Lv31
240 积分 2025-01-07 加入
Sequential Targeting in Multiple Myeloma: Talquetamab, a GPRC5D bispecific antibody, as a Bridge to BCMA CAR-T cell therapy
14天前
已完结
The methionine cycle and its cancer implications
1个月前
已完结
Coordinated regulation of self-renewal and cell cycle during human lympho-myeloid lineage restriction
3个月前
已关闭
Defective neutrophil clearance in JAK2V617F myeloproliferative neoplasms drives myelofibrosis via immune checkpoint CD24
3个月前
已完结
Lasalocid A selectively induces the degradation of MYD88 in lymphomas harboring the MYD88 L265P mutation
5个月前
已关闭
Lasalocid A selectively induces the degradation of MYD88 in lymphomas harboring the MYD88 L265P mutation
5个月前
已完结
Lasalocid A selectively induces the degradation of MYD88 in lymphomas harboring the MYD88 L265P mutation
5个月前
已关闭
Lasalocid A selectively induces the degradation of MYD88 in lymphomas harboring the MYD88 L265P mutation
5个月前
已完结
Establishment and molecular characterisation of patient-derived organoids for primary central nervous system lymphoma
6个月前
已完结
CAR T or NK cells targeting mismatched HLA-DR molecules in acute myeloid leukemia after allogeneic hematopoietic stem cell transplant
7个月前
已完结
皖公网安备34019202002308
